kidney failure semaglutide Ozempic has benefits for disease as well as diabetes FDA Approves Semaglutide to Reduce

The way Ozempic changes digestion may cause sulfur burps and diarrhea in a small percentage of people

Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD

Evidence shows it can drive aging in other organs

Chris is a renowned expert, clinician, and educator in the fields of Functional Medicine and ancestral health

November 25, 2025 PRESSADVANTAGE LifeRx.md announced that it has implemented reduced pricing for its personalized GLP-1 and GIP treatment programs, a development the organization states is intended to align with the federal governments ongoing pursuit of nationwide affordability measures for these treatments